May 31–June 1, 2006 – New York, NY

  Click here for the complete meeting agenda.

  Click here for meeting minutes.

All links below are in PowerPoint file format unless otherwise indicated

Centers For Disease Control and Prevention Update

·         Steve Shapiro, CDC National IPP Coordinator

Targeting Chlamydia Screening Resources

·         Proposed CDC “Measures of Effectiveness,” Kelly Opdyke

·          Region II IPP Activities to Address Proposed “Measures of Effectiveness”

o        Screening “Audit” Methodology, Preeti Pathela

Gonorrhea Screening – What Do the Data Tell Us?

·         Overview of Region II IPP Prevalence Monitoring Data, Kelly Opdyke

·         Decline of GC Morbidity in NYC, Preeti Pathela

·         Oral GC Screening Data, Dr. Hermes Garcia

Promote the Use of High Quality Diagnostics Tests for Chlamydia

·         CDC Update – Laboratory Perspective, Rick Steece, CDC National Chlamydia Laboratory Consultant

o        Supplemental Testing – New Data/Research

o         Results from CDC/APHL 2004 National Lab Survey

o        NAAT non-genital

·         Results from NYC 2004 Lab Survey, Preeti Pathela

Treatment Verification Rates for Chlamydia and Gonorrhea

·         Region II IPP Performance Measures Results, Kelly Opdyke

Expanding Screening to “At Risk” Populations – “What About the Guys?”

·         Overview of Region II IPP Prevalence Monitoring Data, Kelly Opdyke

Expanding Screening to “At Risk” Populations – Schools

·         Puerto Rico, Inarvis Bonilla

·         NYC, Meighan Rogers

·         Region VI Charter School Screening Project, Dawn Middleton

Private Sector Chlamydia Screening and Program Promotion

·         NYC Provider Survey, Meighan Rogers

·         Tools/Strategies to Interface with Private Providers, Gail Burstein

·         NYS Partnership with Foundations for Healthy Living, Alison Muse

·         Overview of Region II Marketing/Outreach Tools, Dawn Middleton